These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11679104)

  • 1. Hyperkalemia in dialysis patients.
    Ahmed J; Weisberg LS
    Semin Dial; 2001; 14(5):348-56. PubMed ID: 11679104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia.
    Salem MM; Rosa RM; Batlle DC
    Am J Kidney Dis; 1991 Oct; 18(4):421-40. PubMed ID: 1928061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hyperkalemia in dialysis patients.
    Putcha N; Allon M
    Semin Dial; 2007; 20(5):431-9. PubMed ID: 17897250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and prevention of hyperkalemia in end-stage renal disease.
    Allon M
    Kidney Int; 1993 Jun; 43(6):1197-209. PubMed ID: 8315933
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease.
    Allon M; Dansby L; Shanklin N
    Am J Med; 1993 May; 94(5):475-482. PubMed ID: 8498392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperkalemia in the chronic renal failure: is it always the aldosterone the responsible?].
    Martin R; Arrizurieta de Muchnik E
    Medicina (B Aires); 1982; 42(4):445-7. PubMed ID: 15171028
    [No Abstract]   [Full Text] [Related]  

  • 7. Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
    Montoliu J; Lens XM; Revert L
    Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms.
    Shavit L; Lifschitz MD; Epstein M
    Kidney Int; 2012 May; 81(10):955-968. PubMed ID: 22336987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.
    Fishbane S; Ford M; Fukagawa M; McCafferty K; Rastogi A; Spinowitz B; Staroselskiy K; Vishnevskiy K; Lisovskaja V; Al-Shurbaji A; Guzman N; Bhandari S
    J Am Soc Nephrol; 2019 Sep; 30(9):1723-1733. PubMed ID: 31201218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure.
    Conte G; Dal Canton A; Imperatore P; De Nicola L; Gigliotti G; Pisanti N; Memoli B; Fuiano G; Esposito C; Andreucci VE
    Kidney Int; 1990 Aug; 38(2):301-7. PubMed ID: 2402122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrarenal potassium homeostasis with maximal exercise in end-stage renal disease.
    Clark BA; Shannon C; Brown RS; Gervino EV
    J Am Soc Nephrol; 1996 Aug; 7(8):1223-7. PubMed ID: 8866416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic renal disease progression: treatment strategies and potassium intake.
    Sinha AD; Agarwal R
    Semin Nephrol; 2013 May; 33(3):290-9. PubMed ID: 23953806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: an evaluation of the evidence.
    Evans K; Reddan DN; Szczech LA
    Semin Dial; 2004; 17(1):22-9. PubMed ID: 14717808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [beta-Sympathomimetics against hyperkalemia in kidney failure].
    Rambausek M; Kluge R
    Dtsch Med Wochenschr; 1993 Jan; 118(4):120-1. PubMed ID: 8428555
    [No Abstract]   [Full Text] [Related]  

  • 15. Potassium. The intracellular cation.
    Gardner KD
    Prim Care; 1975 Mar; 2(1):161-9. PubMed ID: 1046684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.
    Allon M; Shanklin N
    Am J Kidney Dis; 1996 Oct; 28(4):508-14. PubMed ID: 8840939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hyperkalemia in patients with chronic kidney disease--a focus on medications.
    Raymond CB; Sood AR; Wazny LD
    CANNT J; 2010; 20(3):49-53; quiz 54-5. PubMed ID: 21038829
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia.
    Allon M; Takeshian A; Shanklin N
    Kidney Int; 1993 Jan; 43(1):212-7. PubMed ID: 8433561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperkalemia in end-stage renal disease: mechanisms and management.
    Allon M
    J Am Soc Nephrol; 1995 Oct; 6(4):1134-42. PubMed ID: 8589279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approach to hyperkalemia.
    Kim HJ; Han SW
    Nephron; 2002; 92 Suppl 1():33-40. PubMed ID: 12401936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.